ARTICLE | Financial News
Corixa down on PVAC data
February 15, 2001 8:00 AM UTC
CRXA was off $5.375 (22 percent) to $19.438 on Thursday. After the market close on Wednesday, the company said that in a study of 241 psoriasis patients, its PVAC M. vaccae immunotherapeutic was well ...